<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00379535</url>
  </required_header>
  <id_info>
    <org_study_id>0501101</org_study_id>
    <secondary_id>PHRC</secondary_id>
    <nct_id>NCT00379535</nct_id>
  </id_info>
  <brief_title>Preventing Lack of Iodine During Pregnancy</brief_title>
  <official_title>Phase III : Preventing Lack of Iodine During Pregnancy. Effect of Supplying Woman With Potassium Iodine to the Neuro-Cognitive Children Development Until Two Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of potassium iodide during pregnancy on
      neuro-cognitive development of children followed up until two years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      374 patients with pregnancy less 12 weeks amenorrhea

      Patients randomized in 2 parallel groups (each group with 187 patients)

        -  one group with 200 µg of potassium iodide

        -  one group with placebo

      Follow up during 3 years with :

        -  a selection visit, an inclusion with randomization before 12 weeks amenorrhea

        -  and follow up visit at the 5th month and 8th month of pregnancy, the day of birth, and
           6, 12, and 24 months &quot; post partum &quot;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Supplying a daily dose of 200 µg of potassium iodide in comparison with a placebo dose to pregnant woman and evaluate the impact on neuro-cognitive development of children followed up until two years</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of hypothyroxinemia and hypothyroidism during pregnancy</measure>
    <time_frame>9 months max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the functional thyroid parameters of mother during iodine treatment</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the psychometric development of children , for woman with and without treatment</measure>
    <time_frame>6, 12, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantify the iodine supply from the woman to the baby during the breast feeding for woman with and without iodine treatment</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">374</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily dose of 200 µg of potassium iodide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily dose of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>potassium iodide</intervention_name>
    <description>per os</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Iodence</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>per os</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with pregnancy less 12 weeks amenorrhea , with clinically normal pregnancy,
             unique or twiny

          -  Patients who agree to take part in the study and able to sign an Informed Consent Form

        Exclusion Criteria:

          -  Patients receiving a treatment for thyroid affection, or with thyroid pathology

          -  Patients with a chronic pathology like insulin dependent diabetes or arterial
             hypertension

          -  Patients with a treatment supplying iodine or having had a gynecologic exam with a
             iodine solution in the last 30 days

          -  Patients taking part in another clinical test or in the last 30 days

          -  Patients with depressive antecedent before pregnancy or taking antidepressant
             treatment

          -  Psychiatric troubles that may interfere with the clinical evaluation

          -  Patients under special supervision or trusteeship

          -  No social security cover
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CARON PHILIPPE, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>WEMEAU Jean-Louis, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHRU LILLE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>NICCOLI-SIRE Patricia, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Timone MARSEILLE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BRUCKER-DAVIS Francoise, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Nice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinology - University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Caron P, Hoff M, Bazzi S, Dufor A, Faure G, Ghandour I, Lauzu P, Lucas Y, Maraval D, Mignot F, Réssigeac P, Vertongen F, Grangé V. Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid. 1997 Oct;7(5):749-54.</citation>
    <PMID>9349578</PMID>
  </reference>
  <reference>
    <citation>Caron Ph, D Glinoer La fonction thyroïdienne au cours de la grossesse La Thyroïde. De la physiologie cellulaire aux dysfonctionnements. Des concepts à la pratique. Ed Expansion Scientifique - Paris, 2001, 495-500.</citation>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2006</study_first_submitted>
  <study_first_submitted_qc>September 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2006</study_first_posted>
  <last_update_submitted>October 10, 2011</last_update_submitted>
  <last_update_submitted_qc>October 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy , lack of iodine</keyword>
  <keyword>lack of iodine during pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

